Omega Healthcare Investors, Inc.
OHIReal Estate Reit Healthcare Facilities
Omega Healthcare Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 13.2% from fiscal 2024.
- Revenue
- +9.30%
- EPS
- −54.2%
- Free cash flow
- n/m
- Total debt
- −19.5%
Quarter to September 2026, against a year earlier
After hours trading: 45.09, down 0.97%, last trade 7:27pm Eastern.
Follow OHI
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 4.65% in Q3 FY26, the lowest of these four quarters. ROE, at 14.1%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 11.6% | 12.2% | 16.1% | 14.0% |
| ROIC | 8.0% | 4.9% | 9.1% | 4.6% |
Debt
Net debt is 18.37× a year’s EBITDA. Debt is 0.70× equity, against 0.81× in Q1 FY26.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.0× | 0.8× | 0.0× | 0.7× |
| Net debt / EBITDA | 0.7× | 15.7× | −0.6× | 18.4× |
Per share, from Q4 FY25
Since Q4 FY25, per share: free cash flow has grown 299.1%; revenue has grown 5.72%; book value has grown 1.67%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 0.9× | 10.0× | 4.0× |
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Book value | 1.0× | 1.0× | 1.0× | 1.0× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 6 | 6 |
| 11.63% | 12.18% | 16.09% | 14.05% | ||
| 5.93% | 6.34% | 8.48% | 7.46% | ||
ROIC |
7.96% | 4.88% | 9.08% | 4.65% | |
Return on Tangible Assets |
7.04% | 7.98% | 10.60% | 9.29% | |
Average Days of Receivables |
187.42 | 104.80 | 155.52 | 147.49 | |
Free Cash Flow per Share |
0.28 | 0.24 | 2.78 | 1.11 | |
Free Cash Flow |
81.06 | 70.42 | 832.24 | 337.16 | |
Capital Expenditures |
(797.49) | (841.68) | (58.31) | (517.71) | |
| Other line items | |||||
Cash ROIC |
1.41% | 0.71% | 14.27% | 3.37% | |
Accounts Receivable Turnover |
2.49 | 3.54 | 2.88 | 2.97 | |
Tax Rate |
(0.02) | (0.02) | (0.02) | (0.02) | |
Selling, General and Administrative Expense of Revenue |
8.75% | 7.94% | 9.11% | 10.15% | |
Share Based Compensation of Revenue |
3.71% | 3.15% | 4.15% | 5.16% | |
Interest Coverage |
3.33 | 3.62 | 3.82 | 3.66 | |
Operating CF/Net income |
1.49 | 1.44 | 1.02 | 1.11 | |
Depreciation/Fixed assets |
0.05 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
(2.44) | (2.54) | (0.17) | (1.53) | |
Revenue per Share |
4.08 | 4.16 | 4.29 | 4.31 | |
Operating CF per Share |
3.01 | 3.07 | 2.98 | 2.81 | |
Capex per Share |
(2.73) | (2.83) | (0.20) | (1.70) | |
Capex to Sales |
0.67 | 0.68 | 0.05 | 0.39 |